TP53 and cancer: In mice, Trp53 germline nullizygosity predominantly leads to T cell lymphomas at 3–5 months of age, and heterozygous mice develop a greater spectrum of cancers (including lymphomas and sarcomas) but at a much later age than the homozygotes (21–23).